Evidence map›Paper›PMID 38624538›Full record

ArticleInternational journal of mechanics and materials in design2020

Potential of combating transmission of COVID-19 using novel self-cleaning superhydrophobic surfaces: part II-thermal, chemical, and mechanical durability.

Assem Elzaabalawy, S A Meguid

Abstract read
In one paragraph

Article in International journal of mechanics and materials in design, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Advances in the development of superhydrophobic and icephobic surfaces.International journal of mechanics and materials in design · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Assem ElzaabalawyMechanics and Aerospace Design Lab, University of Toronto, 5 King's College Rd, Toronto, ON M5S 3G8 Canada.ORCID https://orcid.org/0000-0002-8144-445X
S A MeguidMechanics and Aerospace Design Lab, University of Toronto, 5 King's College Rd, Toronto, ON M5S 3G8 Canada.ORCID 0000-0001-7151-9932

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In part I, we identified encapsulation, contamination suppression, and virus elimination as our three governing strategies for developing surfaces to combat the transmission and spread of COVID-19. We showed that our recent superhydrophobic nanocomposites has the potential of encapsulating and suppressing the virus so as to limit its transmission and spread. In this study, we examine the durability of the newly developed surfaces when subjected to elevated temperature, chemical attack and mechanical damage in the form of abrasion and compressive load. Extensive tests were conducted to reveal the effect of these parameters on the surface performance. Three aspects of the work were accordingly examined. The first was concerned with controlled thermal stability tests in which the surfaces were subjected to elevated temperatures approaching 350 °C for silicone-based nanocomposites and 150 °C for epoxy-based nanocomposites. The second was concerned with subjecting the surfaces to alkaline and acidic solutions with pH concentrations ranging between 1 and 13. Finally, the third involved surface damage by abrasion tests. Our results show clearly that the newly developed superhydrophobic surfaces are capable of resisting the adverse effects of thermal and chemical attacks as well as mechanical abrasion owing to the excellent structural stability and mechanical properties of the constituents of the nanocomposite. Moreover, our superhydrophobic monolith demonstrated exceptional regenerative capabilities even after being subjected to damaging compressive stresses of up to 10 MPa.

Indexed as

ChemicalCombatCOVID-19DurabilityMechanicalSuperhydrophobicThermal

Identifiers

PMID38624538
PMCPMC7405720

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.